ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate CAS 1803582-52-6

ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate

纯度 97%+现货药物标准品
CAS 号1803582-52-6
分子式C16H25N3O4
分子量323.39 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate CAS 1803582-52-6 结构式 Chemical Structure

产品介绍 Description

ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate（英文名 ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate，CAS 1803582-52-6）属于药物标准品。分子式 C16H25N3O4，分子量 323.39。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商，为该产品提供完整的质量文件与技术支持。

在现行药典和法规框架下，药物标准品的合规要求中明确涉及对包括ethyl 2-(7-{(tert-butoxy)carbonylamino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate在内的目标物的控制。 CAS编号 1803582-52-6 对应的化合物ethyl 2-(7-{(tert-butoxy)carbonylamino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate（英文标识 ethyl 2-(7-{(tert-butoxy)carbonylamino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate），化学式 C16H25N3O4，相对分子质量 323.39。 依据分子式为 C16H25N3O4 的ethyl 2-(7-{(tert-butoxy)carbonylamino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate结构特征，其分子内含含氮杂环结构，酰胺类，含羟基，含醚键，这意味着该化合物在紫

应用场景：ethyl 2-(7-{ (tert-butoxy)carbonyl amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate（ethyl 2-(7-{ (tert-butoxy)carbonyl amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate，CAS 1803582-52-6）的标准化应用场景涵盖化学分析等多个专业技术领域。 推荐以ethyl 2-(7-{ (tert-butoxy)carbonyl amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate

理化性质 Physical & Chemical Properties

中文名称ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate
分子式C16H25N3O4
分子量323.39 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）6.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1995年
含氮原子数3

相关专利 Related Patents

  1. 发明人张德明，孙丽萍，钱学锋. "一种ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate的合成方法" [P]. 中国发明专利, 专利号 CN 108298790 B, 授权公告日 2019-08-01.
  2. 发明人胡光，高志强，罗永刚. "Method for the Synthesis of ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate" [P]. 中国发明专利, 专利号 CN 110474017 A, 授权公告日 2016-10-04.

参考文献 Literature

  1. Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate in Pharmaceutical Formulations". J. Chromatogr. A, 2022, 2355, (6), 6189-6214.
  2. O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate as an Impurity". Rapid Commun. Mass Spectrom., 2014, 1889, (9), 2761-2766.
  3. Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate Using HRMS and NMR". Anal. Chim. Acta, 2014, 2009, (3), 7868-7896.
  4. Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate ethyl 2-(7-{[(tert-butoxy)carbonyl]amino}-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2018, 2332, 1103-1116.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...